Feedback / Questions
ubidecarenone IV (BPM31510 IV) - BPGbio
https://www.globenewswire.com/news-release/2026/01/20/3221557/0/en/BPGbio-Receives-FDA-Orphan-Drug-Designation-for-BPM31510-for-the-Treatment-of-Primary-CoQ10-Deficiency.html
Jan 20, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next